Herramientas de usuario
es:tema:corona:hidroxicloroquina
Diferencias
Muestra las diferencias entre dos versiones de la página.
| Ambos lados, revisión anterior Revisión previa Próxima revisión | Revisión previa | ||
|
es:tema:corona:hidroxicloroquina [2020/06/04 22:13] geronimo |
es:tema:corona:hidroxicloroquina [2020/06/10 23:03] (actual) geronimo [Referencias] |
||
|---|---|---|---|
| Línea 13: | Línea 13: | ||
| [[https://doi.org/10.1056/NEJMoa2012410|{{:es:tema:corona:geleris_et_al_20_nejmed_-_hidroxichloroquina_-_fig_2.png?200|}}]] | [[https://doi.org/10.1056/NEJMoa2012410|{{:es:tema:corona:geleris_et_al_20_nejmed_-_hidroxichloroquina_-_fig_2.png?200|}}]] | ||
| + | Ademas, en el ensayo clinical "[[ https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19|RECOVERY]]" (declarado el 5 Junio), los científicos no revelaron ningún beneficio clínico del uso de hidroxicloroquina en pacientes hospitalizados con COVID-19. | ||
| ====== Referencias ====== | ====== Referencias ====== | ||
| * Geleris, Joshua, Yifei Sun, Jonathan Platt, Jason Zucker, Matthew Baldwin, George Hripcsak, Angelena Labella, et al. « [[ https://doi.org/10.1056/NEJMoa2012410|Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19]] ». New England Journal of Medicine | * Geleris, Joshua, Yifei Sun, Jonathan Platt, Jason Zucker, Matthew Baldwin, George Hripcsak, Angelena Labella, et al. « [[ https://doi.org/10.1056/NEJMoa2012410|Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19]] ». New England Journal of Medicine | ||
| - | * Mehra, Mandeep R., Sapan S. Desai, Frank Ruschitzka, et Amit N. Patel. « [[ https://doi.org/10.1016/S0140-6736(20)31180-6|Hydroxychloroquine or Chloroquine with or without a Macrolide for Treatment of COVID-19: A Multinational Registry Analysis]] ». The Lancet 0, nᵒ 0 (22 mai 2020). | + | * Horby & Landray. " [[ https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19|No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19]] ". |
| * Rosenberg, Eli S., Elizabeth M. Dufort, Tomoko Udo, Larissa A. Wilberschied, Jessica Kumar, James Tesoriero, Patti Weinberg, et al. « [[ https://doi.org/10.1001/jama.2020.8630|Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State]] ». JAMA, 11 mai 2020. | * Rosenberg, Eli S., Elizabeth M. Dufort, Tomoko Udo, Larissa A. Wilberschied, Jessica Kumar, James Tesoriero, Patti Weinberg, et al. « [[ https://doi.org/10.1001/jama.2020.8630|Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State]] ». JAMA, 11 mai 2020. | ||
/var/www/vhosts/autono-medic.ouvaton.org/httpdocs/data/attic/es/tema/corona/hidroxicloroquina.1591301622.txt.gz · Última modificación: 2020/06/04 22:13 por geronimo
Excepto donde se indique lo contrario, el contenido de este wiki esta bajo la siguiente licencia: GNU Free Documentation License 1.3
